ACTIVE INVESTORS WEEKLY MONITOR PART 2

Share
Subscribe

In part II of this week’s blog, we note another 3 investors profiled on our platform, who have announced investments in recent days. These investors could very well be interested in your company, so take a look at what they’ve been up to below, then log in to Match Capital to see how you measure up to them using our relevancy algorithm. You will find a complete breakdown of all these investors, their strategies and previous investments, how you’re connected to them and more on the Match Capital platform.

Login if you are a returning entrepreneur, or Sign up for your first Match Capital experience.

 

SV Life Sciences (Website) (LinkedInSV life sciences

SV Life Sciences is a leading international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the firm closed its first dedicated life sciences fund in 1994.The SVLS team manages five private venture capital funds with approximately $1.9 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health-care services. SVLS has offices in Boston, London and San Francisco.

Most noteworthy investment:

http://www.finsmes.com/2016/09/artios-pharma-raises-33-2m-in-series-a-funding.html

 

Merck Ventures (Website) (LinkedInMerck Ventures

They drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck’s current and future businesses. They are the strategic, corporate venture capital arm of Merck. They mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel they invest globally in transformational ideas driven by great entrepreneurs.

Most noteworthy investment:

http://www.finsmes.com/2016/09/artios-pharma-raises-33-2m-in-series-a-funding.html

 

Imperial Innovations (Website) (LinkedIn)Imperial

Focused on commercializing leading UK academic research, sourced from the ‘golden triangle’ that is formed between Cambridge, Oxford and London, Imperial Innovations is a company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Imperial innovations is focused on commercializing the most promising UK academic research across a broad range of technology sectors, their expertise lying in therapeutics, medtech, engineering and materials, and information communication technology.

Most noteworthy investment:

http://www.finsmes.com/2016/09/artios-pharma-raises-33-2m-in-series-a-funding.html

 

Vaibhv Gaur (163 Posts)

Vaibhv is Head of Business Analysis and Data Management at Match Capital. Vaibhv keeps an eye on deals happening in the venture capital industry – tracking the key players to grow our database of investors.


Vaibhv is Head of Business Analysis and Data Management at Match Capital. Vaibhv keeps an eye on deals happening in the venture capital industry – tracking the key players to grow our database of investors.

Back to top